Coronavirus disease 2019 (COVID-19) was first identified in November 2019 in Wuhan, Hubei province in China. Since then the disease has rapidly spread to become a global pandemic, affecting all sectors of our society and all aspects of our lives, even for those who were not affected directly by the virus. We therefore should congratulate Nicola et al. \[[@bib1]\] for the excellent up-to-date review on the socio-economic outcomes of the COVID-19 pandemic. The authors have chosen to describe a highly relevant topic that influences the daily living of people worldwide.

Everything is now rapidly changing. Most specifically, the COVID-19 pandemic will have a big impact on the healthcare sector and its interactions with the "customers", the patients. In light of all the published data in the digital media, the COVID-19 pandemic raised a lot of concern among patients, especially the elderly and those with chronic diseases. The anxiety and fear of infection causes a significant delay in seeking medical care due to other unrelated medical conditions -- both acute and chronic. For example, in the single-center study by Tam et al. \[[@bib2]\], the authors reported a significant delay in time to seeking medical help in patients with ST segment elevation myocardial infarction. These delays may be explained by the fear of patients from attending the emergency room and possible exposure to infected patients and also by the time it takes for physicians to properly protect themselves when treating suspected or confirmed patients. In addition, lack of physical activity and weight gain during quarantine and the decision to postpone elective procedures, may possibly result in an increase in cancer incidence and cardiovascular events in the near future.

As a result, we should now seek for new solutions and for novel pathways to communicate medical care to our patients. We, the caretakers, should call for action to our governments, to the emergency medical services, to our hospital managements - to acquire a technology that is capable of gathering medical data from a distance, a system that is capable of monitoring patient status and reaching diagnoses without physically seeing the patient. These telemedicine systems should be simple, convenient and affordable for real-time consultation between patients and care providers, between rural or community hospitals and surgeons in centers of expertise, for improved decision-making in emergency and routine daily situations \[[@bib3]\]. This is the time for the biotechnology industry together with the health economy decision-makers and government officials to apply the revolution of telemedicine to larger portions of the population, making it available worldwide. We should implement these telemedicine systems only after an intensive quality assurance research in large-scale, randomized clinical trials that will convince the medical community that telemedicine is the next medical revolution. The COVID-19 pandemic should be the spark that will ignite the fire of reachable and affordable global telemedicine.
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